BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Integrated DNA Technologies Release: Providing Cost-Effective Capture of Defined Genomic Regions


8/12/2013 9:48:08 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CORALVILLE, IA – 12 August 2013 – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides researchers in Prof Jeffrey Barrick’s laboratory (University of Texas at Austin, USA) with its xGEN® Lockdown® Probes for target enrichment of specific gene regions. Detailed in the DECODED quarterly newsletter from IDT, Prof Barrick’s research team is developing methods to track rare mutations in evolving populations to assess effects on fitness from sequence alone. Through the use of the xGEN Lockdown Probes, the research team obtained greater depth of coverage, sequencing only the regions of interest. As a result, the volume of data they collected and their subsequent data analysis were reduced, while the researchers saved on the cost of sequencing reagents. Dr Daniel Deatherage, a postdoctoral associate in the Barrick laboratory, commented, “One of the nice things about the IDT probes is that we could start from a single biotinylated probe and expand to a whole pool of the xGEN Lockdown Probes.” xGEN Lockdown Probes are individually synthesized and assessed by mass spectroscopy for quality control, enabling a seamless transition from discovery to clinical application.

To find out more, the article ‘Target Enrichment Identifies Mutations that Confer Fitness Effects’ is available in the latest issue of DECODED. For more information please visit www.idtdna.com. Follow us on twitter @idtdna for real-time updates and insights.

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the world, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; Leuven, Belgium; and Singapore. For more information visit www.idtdna.com.

Integrated DNA Technologies

800-328-2661 (US & Canada)

+1 319-626-8400 (outside US)

productinfo@idtdna.com

www.idtdna.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES